Sight Sciences Inc. (SGHT): Kapitalisasi marang pendapatan

Simbol lan logo merek Sight Sciences Inc. (SGHT)

Sight Sciences, Inc. (SGHT) is implementing eco-friendly standards in the production of ophthalmological equipment by reducing plastic usage. The price-to-sales ratio visualizes the dynamics of this process, where the 6.80 level indicates the status of the parameter. Stable demand is driven by the unique ergonomics of its microsurgical instruments. Meanwhile, Sight Sciences, Inc. (SGHT) is mitigating regulatory risks in the glaucoma treatment segment through the systematic training of physicians in new methodologies.

SGHT Multiplikator P/S Sight Sciences Inc. (04.07.2022 - 14.11.2026)

Rincian analitis perusahaan Sight Sciences, Inc (SGHT)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:SGHT sightsciences.com
Barang utama Sight Sciences, Inc.

Professional selection of sustainable assets requires aligning a business's market value with actual sales volume to avoid overpaying for an asset. By analyzing the price/sales multiple, an investor assesses the ratio of market capitalization to annual revenue, which is particularly critical for Sight Sciences, Inc. (SGHT), where high R&D expenditures and the development of OMNI systems make this metric a key indicator of the effectiveness of innovation commercialization.

Pesaing Sight Sciences, Inc.

BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (Iradimed) - Kapitalisasi marang pendapatan|Embecta Health - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Diabetes Care) - Multiplikator P/S|Rega marang dodolan axogeninc.com AXGN|Rasio rega marang pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Multiplikator rega marang pendapatan|Bioventus Corp - Kapitalisasi marang pendapatan|Multiplikator P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator P/S|Koefisien rega marang pendapatan blade.com SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Inc)|Rasio rega marang pendapatan ClearPoint Neuro Inc.|Kapitalisasi marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator P/S STIM|OBIO - Rega marang dodolan|Rasio rega marang pendapatan Anika Therapeutics, Inc. ANIK|NSPR: Rasio kapitalisasi marang pendapatan|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical, Inc. - Kapitalisasi marang volume dodolan|xtantmedical.com (XTNT) - Rasio rega marang pendapatan|NMTC - Koefisien rega marang pendapatan|MODD (Modular Medical Inc) - Multiplikator P/S|Myomo Inc. (MYO) - Koefisien rega marang pendapatan|Multiplikator P/S COCH|Vivos Therapeutics Inc (VVOS) - Multiplikator rega marang pendapatan|Multiplikator P/S NVNO (enVVeno Medical)|Rasio kapitalisasi pasar marang pendapatan SINT|TNON: Kapitalisasi marang pendapatan|ReWalk Robotics - Kapitalisasi marang volume dodolan|AMIX (autonomix.com) - Kapitalisasi marang pendapatan|INVO Fertility Corp - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Bone Biologics|axonics.com (AXNX) - Koefisien rega marang pendapatan|Multiplikator P/S BIOL|Kapitalisasi marang pendapatan dynatronics.com DYNT|Multiplikator P/S FNA (Paragon 28)|Koefisien rega marang pendapatan INVO Bioscience Inc. (INVO)